Blood donation during radiotherapy

PROCEDURE2 trials

Sponsors

Institute of Cancer Research, United Kingdom

Conditions

Cancer

Unknown Phase

Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects

CompletedNCT02780375

Institute of Cancer Research, United KingdomCancer

Start: 2016-09-12End: 2018-07-17Updated: 2018-10-31

Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)

Active, not recruitingNCT03809377

Institute of Cancer Research, United KingdomCancer

Start: 2019-05-09End: 2026-06-01Updated: 2026-03-27